Study in HFpEF patients to compare the effect of AZD9977 and Spironolactone on Serum Potassium

Trial Identifier: D6401C00004
Sponsor: AstraZeneca
NCTID:: NCT03682497
Start Date: November 2018
Primary Completion Date: March 2020
Study Completion Date: March 2020
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Bulgarian Translation
Czech Translation
Polish Translation

Trial Locations

Country Location
Bulgaria Plovdiv, Bulgaria, 4002
Bulgaria Sofia, Bulgaria, 1784
Bulgaria Sofia, Bulgaria, 1309
Czech Republic Brandys nad Labem, Czech Republic, 250 01
Czech Republic Ceska Lipa, Czech Republic, 470 77
Czech Republic Jaromer, Czech Republic, 551 01
Czech Republic Louny, Czech Republic, 440 01
Czech Republic Pardubice, Czech Republic, 530 02
Czech Republic Praha, Czech Republic, 130 00
Czech Republic Praha, Czech Republic, 140 59
Poland Katowice, Poland, 40-081
Poland Kraków, Poland, 31-202
Poland Legnica, Poland, 59-220
Poland Warszawa, Poland, 02-097
Poland Wrocław, Poland, 50-981
United Kingdom Barnet, United Kingdom, EN5 3DJ
United Kingdom HULL, United Kingdom, HU3 2JZ
United Kingdom Leicester, United Kingdom, LE3 9PQ
United Kingdom Sheffield, United Kingdom, S5 7AU